Fundraising FoxIlluminare Biotechnologies
Brooklyn, US · Founded 2016 · Delaware corporation · 1 known investors
Find your way into Illuminare Biotechnologies
Sign up to find every way you can get introduced to Illuminare Biotechnologies
- Your email: who you already know at Illuminare Biotechnologies, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Illuminare Biotechnologies team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
BL
Brian LongstreetExecutive
WG
Walter GreenblattNamed on SEC filing
SY
Sue YaoNamed on SEC filing
Board
OC
Oliver CurmeBoard director
EE
Eric EdidinBoard director
SG
RG
Robert GraifmanBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 2 of 3 rounds · 2017–2026
▶$3.6MraisedJun 2026 · 42 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJun 2026 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ezra AngristPromoter
- Oliver CurmeDirector
- Walter GreenblattExecutive Officer, Director, Promoter
- Eric EdidinDirector
- Andrew FradkinPromoter
- Brian LongstreetExecutive Officer, Director
- Shay GrinfeldDirector, Promoter
- Robert GraifmanDirector, Promoter
- Offering amount
- $4M
- Amount sold
- $3.6M
- Minimum investment
- $1.4K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MofferedDec 2018 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter GreenblattExecutive Officer
- Offering amount
- $2.5M
- Minimum investment
- $5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b, 04.3
▶$2.4MraisedAug 2017 · 44 investors · BiotechnologyRule 506(b)
▶$2.4MraisedAug 2017 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GraifmanDirector
- Shay GrinfeldExecutive Officer, Director
- Sue YaoDirector
- Offering amount
- $2.5M
- Amount sold
- $2.4M
- Minimum investment
- $5K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Illuminare Biotechnologies's investors?
- Illuminare Biotechnologies's investors include Greenfield Partners.
- How much funding has Illuminare Biotechnologies raised?
- Illuminare Biotechnologies has disclosed $6M raised across 2 of its 3 known rounds.
- Where is Illuminare Biotechnologies headquartered?
- Illuminare Biotechnologies is headquartered in Brooklyn, US.